Latest Articles
- EditorialDemystifying MOGAD and Double Seronegative NMOSD Further With IL-6 BlockadeKok Pin Yong, Ho Jin KimDecember 15, 2021
- ArticleSiponimod Inhibits the Formation of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune EncephalomyelitisRosa Margareta Brand, Jolien Diddens, Verena Friedrich, et al.December 15, 2021
- ArticleAllosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in MiceMarija Radosevic, Jesús Planagumà, Francesco Mannara, et al.December 13, 2021
- ArticleCSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial MeningitisNora Chekrouni, Thijs M. van Soest, Matthijs C. Brouwer, et al.December 13, 2021
- ArticleStress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8+ T-Cell BehaviorsAna Carmena Moratalla, Yves Carpentier Solorio, Florent Lemaitre, et al.December 06, 2021
- ArticleRecovery From COVID-19 in Multiple SclerosisA Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis RegisterAfagh Garjani, Rodden M. Middleton, Richard Nicholas, et al.November 30, 2021
- ArticleCOVID-19 Infection in Fingolimod- or Siponimod-Treated PatientsCase SeriesRoseanne Sullivan, Ajay Kilaru, Bernhard Hemmer, et al.November 30, 2021
- ArticleCSF-Derived CD4+ T-Cell Diversity Is Reduced in Patients With Alzheimer Clinical SyndromeChaitanya Joshi, Karthigayini Sivaprakasam, Scott Christley, et al.November 30, 2021
- Views & ReviewsIgG4-Mediated Neurologic AutoimmunitiesUnderstanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell TherapiesMarinos C. DalakasNovember 29, 2021
- ArticleNo Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11C]-PK11195Ruud Raijmakers, Megan Roerink, Stephan Keijmel, et al.November 23, 2021
Pages
Advertisement